Tower Research Capital (TRC)’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio PXMD Stock Details PXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,023	Closed	-$3.58K	–	6193
2024 Q1	$3.58K	Buy	7,023 +276	+4%	+$162	﹤0.01%	4834
2023 Q4	$5.11K	Buy	6,747 +6,283	+1,354%	+$14.6K	﹤0.01%	4880
2023 Q3	$2.25K	Buy	464 +8	+2%	+$77	﹤0.01%	5180
2023 Q2	$6.09K	Buy	456 +220	+93%	+$5.39K	﹤0.01%	4743
2023 Q1	$8K	Sell	236 -85	-26%	-$3.41K	﹤0.01%	4694
2022 Q4	$11K	Buy	321 +211	+192%	+$7.54K	﹤0.01%	3919
2022 Q3	$4K	Buy	+110	New	+$6.21K	﹤0.01%	5321

Other funds holding PXMD

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Tower Research Capital (TRC)'s PXMD Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of PaxMedica, Inc. Common Stock (PXMD) in Q2 2024, closing a stake of 7,023 shares — an estimated $3.58K sold.

Tower Research Capital (TRC) first reported a position in PXMD in Q3 2022 and held it in 7 quarters. The position peaked at $11K in Q4 2022. 1 fund tracked by Wall St. Rank holds PXMD as of Q2 2024.

Tower Research Capital (TRC) reported no remaining PaxMedica, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 7,023 PaxMedica, Inc. Common Stock shares in Q2 2024, an estimated $3.58K.
Tower Research Capital (TRC) first reported a position in PaxMedica, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Tower Research Capital (TRC)'s PaxMedica, Inc. Common Stock position peaked at $11K in Q4 2022.
1 fund tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.